NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Eli Lilly and Company
Revolution Medicines, Inc.
Eli Lilly and Company
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.